Skip to content

Bachem Holding AG

🇨🇭XSWX.BANBSwitzerlandNot reported

CHF 81.45CHFdown -1.60 (-1.93%)ClosedEnd of day5:37 AM

PriceCHF 81.45-1.60 (-1.93%)

Latest anomalies

Neutral 0 detected in the last 120 days

  • High: 2
  • Medium: 0
  • Low: 0
  • Book to market ratio: a sudden spike above its trailing quarter average

    Fundamentals High

  • P/B ratio: a sudden drop below its trailing quarter average

    Fundamentals High

View all anomalies

Free with a Finzer account.

Profile

  • Switzerland

Identity

Type
Stock
ISIN
CH1176493729
CUSIP
Not reported

Company

Employees
2,292
Headquarters
Bubendorf, United Kingdom

Market

Shares outstanding
74.9M
Market cap
CHF 6.11B

Highlights

Day rangeCHF 80.65 - CHF 83.90
today's session
52-week rangeCHF 48.52 - CHF 84.10
from 249 sessions
Market cap
CHF 6.11B
EPS LTM
CHF 1.97
P/E LTM
46.32
Div yield
1.23%

Fundamentals (LTM)

Revenue
CHF 805.08M+61.35%up year on year
Net income
CHF 147.78M+50.53%up year on year
Gross margin
29.63%-6.09%down year on year
Free cash flow
-CHF 91.19M-104.09%down year on year

View all financials

Latest news

News is not sourced for this exchange.

Business summary

Bachem Holding AG is listed on SIX Swiss Exchange (Switzerland) under the ticker BANB. Its market capitalisation is CHF 6.11B, from 74.9M shares outstanding, as of . Across the 249 trading sessions to the shares traded between CHF 48.52 and CHF 84.10, and the last close of CHF 81.45 sits 93% of the way up that range. The company is headquartered in Bubendorf, United Kingdom, and employs about 2,292 people. The same company also trades as 0QND on London Stock Exchange.

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland.